Search Results for citation:"89 FR 106584"

Found 2 results
Skip to main content

Search Results: citation:"89 FR 106584"

  • Type:Notice
    Citation:89 FR 106584
    Reading Time:about a minute or two

    Siegfried USA, LLC has submitted an application to the Drug Enforcement Administration (DEA) seeking approval to become an importer of certain controlled substances. The application is intended to allow the company to import these substances for the purpose of manufacturing bulk Active Pharmaceutical Ingredients for its customers. Interested parties, such as registered bulk manufacturers of these controlled substances, are invited to submit comments or objections to this application by January 29, 2025. Comments should be submitted electronically via the Federal eRulemaking Portal, and requests for a hearing can be sent to the DEA at the addresses provided in the document.

    Simple Explanation

    Imagine a company wants to bring special, controlled medicine ingredients into the country so they can help make important medicines. People and other companies can say what they think about this idea until the end of January next year by sending comments online.

  • Type:Notice
    Citation:89 FR 106584
    Reading Time:about 7 minutes

    The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Dr. Matthew Okeke, who is based in Nevada. This order proposed revoking his DEA registration because he no longer has a valid state license or authority to handle controlled substances in Nevada. Dr. Okeke did not respond to the order, leading the DEA to proceed with final agency action to revoke his registration. The decision was signed by DEA Administrator Anne Milgram and is set to take effect on January 29, 2025.

    Simple Explanation

    The Drug Enforcement Administration (DEA) is taking back Dr. Matthew Okeke’s permission to handle special medicines because he lost his state license in Nevada, and he didn't reply when they asked why they shouldn't do this.